ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

IMVT Immunovant Inc

28,39
-1,17 (-3,96%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:01:10
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Immunovant Inc IMVT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-1,17 -3,96% 28,39 22:01:10
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
29,82 28,28 29,82 28,39 29,56
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
12.3.202412:30GLOBEImmunovant Awarded U.S. Patent for IMVT-1402
23.2.202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202414:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202413:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12.2.202413:02EDGAR2Form 8-K - Current report
29.1.202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.1.202413:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
12.1.202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202414:08EDGAR2Form 8-K - Current report
03.1.202414:00GLOBEImmunovant to Present at the 42nd Annual J.P. Morgan..
20.12.202323:40DJNImmunovant Gets Positive Data From Graves' Disease Treatment..
20.12.202322:37EDGAR2Form 8-K - Current report
20.12.202322:30GLOBEImmunovant Reports Positive Initial Phase 2 Results for..
28.11.202313:43EDGAR2Form 8-K - Current report
28.11.202313:00GLOBEImmunovant Announces Positive IMVT-1402 Initial 600 mg MAD..
24.11.202320:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.11.202320:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.11.202320:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.11.202320:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202314:00GLOBEImmunovant to Present at Upcoming Investor Conferences
09.11.202314:49EDGAR2Form S-3ASR - Automatic shelf registration statement of..
09.11.202313:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202313:06EDGAR2Form 8-K - Current report
09.11.202313:00GLOBEImmunovant Reports Financial Results and Provides Corporate..
20.10.202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.10.202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.10.202323:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.10.202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.10.202322:52GLOBEImmunovant Announces Closing of Upsized Common Stock..
29.9.202322:48EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28.9.202323:23EDGAR2Form 8-K - Current report
28.9.202312:09EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
28.9.202305:41GLOBEImmunovant Announces Pricing of $450 Million Common Stock..
26.9.202323:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26.9.202323:00GLOBEImmunovant Announces Proposed Offering of $300 Million of..
26.9.202313:45EDGAR2Form 8-K - Current report
26.9.202312:00GLOBEImmunovant Announces Positive Initial IMVT-1402 Phase 1 SAD..
26.9.202305:01GLOBEImmunovant to Host Conference Call and Webcast to Report..
01.9.202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.8.202323:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.8.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.8.202322:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.8.202322:48EDGAR2Form 8-K - Current report
16.8.202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.8.202313:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]